Stockscreener 앱 받기
1.14
9.93%
0.09
Fibrobiologics Inc 주식(FBLG)의 최신 뉴스
Fibrobiologics stock plunges to 52-week low of $1.04 By Investing.com - Investing.com Australia
Fibrobiologics stock plunges to 52-week low of $1.04 - Investing.com India
FBLG: Analyst Day Provides In-Depth Overview of Pipeline… - MSN
FibroBiologics' (FBLG) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat
Exploring Growth Opportunities In FibroBiologics Inc (NASDAQ: FBLG) - Stocks Register
D. Boral Capital Reaffirms “Buy” Rating for FibroBiologics (NASDAQ:FBLG) - Defense World
Should This Give FibroBiologics Inc (NASDAQ: FBLG) Investors Sleepless Nights? - Stocks Register
FibroBiologics Inc (FBLG) stock analysis: A comprehensive overview - US Post News
FBLG (FibroBiologics Inc) may reap gains as insiders became active recently - Knox Daily
FBLG Stock Price and Chart — NASDAQ:FBLG - TradingView
FibroBiologics issues shares to fulfill commitment fee - MSN
FibroBiologics issues shares to fulfill commitment fee By Investing.com - Investing.com Australia
FibroBiologics Inc (FBLG) Stock: Navigating a Year of Volatility - The InvestChronicle
FibroBiologics Inc (NASDAQ: FBLG) Has Decreased By -81.41 Percent This Year. Is It A Better Buy Than Others? - Marketing Sentinel
Should You Invest in FibroBiologics Inc (FBLG) Now? - The News Heater
FibroBiologics, Inc. to Host Analyst Day on Fibroblast-Based Therapeutics in New York on February 12, 2025 - Nasdaq
FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates - GlobeNewswire
Exclusive Analyst Day: FibroBiologics to Unveil Future of Fibroblast Therapeutics - StockTitan
FibroBiologics And 2 Other US Penny Stocks To Watch - Simply Wall St
BlackRock, Inc. Increases Stake in FibroBiologics Inc - GuruFocus.com
FibroBiologics approves executive bonuses for fiscal 2024 - MSN
FibroBiologics approves executive bonuses for fiscal 2024 By Investing.com - Investing.com Canada
FibroBiologics, Inc. (NASDAQ:FBLG) Shares Bought by Barclays PLC - Defense World
Jane Street Group LLC Acquires Shares of 11,852 FibroBiologics, Inc. (NASDAQ:FBLG) - Defense World
Geode Capital Management LLC Acquires 284,047 Shares of FibroBiologics, Inc. (NASDAQ:FBLG) - Defense World
Barclays PLC Buys 31,331 Shares of FibroBiologics, Inc. (NASDAQ:FBLG) - Defense World
FibroBiologics, Inc. (NASDAQ:FBLG) Shares Bought by State Street Corp - Defense World
FibroBiologics Secures Second Tranche of $5 Million Financing - Defense World
FibroBiologics Announces $25 Million Financing - citybiz
FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing - GlobeNewswire
FibroBiologics Secures Second $5M Tranche of $25M Equity Purchase Agreement with Yorkville Advisors - StockTitan
D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing - The Manila Times
D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing - GlobeNewswire Inc.
FibroBiologics (NASDAQ:FBLG) Receives Buy Rating from D. Boral Capital - Defense World
D. Boral Capital Reiterates Buy Rating for FibroBiologics (NASDAQ:FBLG) - MarketBeat
**FibroBiologics Enters Standby Equity Purchase Agreement for $25 Million Financing** ** - Defense World
FibroBiologics announces $25 million financing - MSN
FibroBiologics, Inc. announced that it expects to receive $15 million in funding from Yorkville Advisors Global LP - Marketscreener.com
FibroBiologics secures $25 million equity deal with Yorkville - Investing.com
FibroBiologics Secures $25M Equity Agreement for Trials - TipRanks
FibroBiologics Secures $25M Financing Deal to Advance Clinical Trials in Diabetic Foot Ulcers, Psoriasis - StockTitan
FibroBiologics finalizes agreement and terminates warrant By Investing.com - Investing.com Canada
FibroBiologics finalizes agreement and terminates warrant - Investing.com
Ionq Inc (IONQ-N) QuotePress Release - The Globe and Mail
FibroBiologics, Inc. (NASDAQ:FBLG) Short Interest Update - MarketBeat
Rodman & Renshaw Initiates Coverage of FibroBiologics (FBLG) with Buy Recommendation - MSN
FibroBiologics (NASDAQ:FBLG) Coverage Initiated at Rodman & Renshaw - MarketBeat
FibroBiologics, Inc. (NASDAQ:FBLG) Short Interest Up 7.2% in November - MarketBeat
0.11%
0.83%
자본화:
|
볼륨(24시간):